Corporate 2010Annual Report En.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
THE GLOBAL FUND ANNUAL REPOrt 2010 ACKNOWLEDGEMENTS This report was written by Beatrice Bernescut, Ian Grubb, Ralf Jürgens and Paula Hacopian, with valuable contributions by Ian Carter, Eric Godfrey, Liam McDowall, Sunny Park and Rui Manuel Teixeira. Design and Layout: Art Gecko – [email protected] The geographical designations employed in this publication do not represent or imply any opinion or judgment on the part of the Global Fund to Fight AIDS, Tuberculosis and Malaria on the legal status of any country, territory, city or area, on its governmental or state authorities, or on the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers, products does not imply that they are endorsed or recommended by the Global Fund in preference to others of a similar nature that are not mentioned. Inclusion of persons in photos should not be construed as indicating their health status. All rights reserved. This document may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The Global Fund accepts contributions from governments, corporations, foundations and individuals. To contribute, please visit our website or contact the External Relations team at [email protected]. For more information and updates on the status of the Global Fund, visit www.theglobalfund.org ISBN 978-92-9224-270-1 © The Global Fund to Fight AIDS, Tuberculosis and Malaria This report was published in May 2011. All information in this report relates to data as of 31 December 2010. The Global Fund Annual Report 2010 | 3 TABLE OF CONTENTS ANNUAL REPORT 2010 4 LETTER FROM THE EXECUTIVE DIRECTOR 6 LETTER FROM THE CHAIR AND VICE-CHAIR OF THE BOARD 8 YEAR IN REVIEW 13 LIST OF TECHNICAL REVIEW PANEL AND BOARD MEMBERS 17 LIST OF PLEDGES AND CONTRIBUTIONS 25 LIST OF APPROVED GRANTS 45 FINANCIAL STATEMENTS 4 | The Global Fund Annual Report 2010 LEttER FROM THE EXECUTIVE DIRECTOR As the Global Fund partnership gathered in Sofia for the Twenty-second Board meeting at the end of 2010, we were able to reflect upon another year in which the Global Fund vigorously pursued its mission of supporting countries around the world to fight AIDS, TB and malaria and to further strengthen health systems and community-based services. Disbursements in 2010 exceeded treated nets and indoor residual of programs to prevent mother-to- US$ 3 billion for the first time spraying – is the leading contributor child/vertical HIV transmission. Over (compared to just US$ 1 billion to reduced child mortality. And TB US$ 70 million in existing HIV grants in 2005), showing that countries mortality has fallen by more than a was reprogrammed in 11 of the 20 are continuing to rapidly scale up third since 1990, with a significant countries that account for 80 per programs and significantly increase drop in the last five years. By the end cent of the global burden of vertical the coverage of key interventions of 2010, an estimated 6.5 million transmission. Nearly 20 countries for the three diseases. lives had been saved by programs initiated a switch from single-dose that the Global Fund supports. nevirapine to the more efficacious Evidence of impact of these drug regimens recommended by programs continues to grow. The The Global Fund way of working as the World Health Organization number of new HIV cases globally a partnership allows us to leverage (WHO). Ten high-burden countries has fallen more than 20 per cent the impact of our investments more in sub-Saharan Africa committed since 1997. There is mounting effectively. In 2010, for example, to the target of virtual elimination evidence that scaling up malaria an intensive effort was made to of vertical HIV transmission by control - especially with insecticide- improve the quality and coverage 2015 or earlier in the framework of The Global Fund Annual Report 2010 | 5 their Global Fund grant. This was a Fund’s third-largest round. This The Global Fund strong example of the Global Fund round included an extraordinary way of working partnership in action. The Affordable success rate for malaria proposals as a partnership Medicines Facility - malaria, hosted of approximately 80 per cent, some by the Global Fund, provides disappointments with regard to allows us to another remarkable example of a HIV proposals and US$ 130 million leverage the public-private partnership in action committed over five years through impact of our to expand access to lifesaving the funding stream for most-at-risk investments more medicines. With the introduction populations, which offered a new of a co-payment to manufacturers opportunity to access resources for effectively. of the most effective malaria drugs, these groups. retail prices for artemisinin-based combination treatments have fallen Looking ahead to 2011, the Board dramatically in several participating and Secretariat will need to work countries and it is hoped that they together closely to resolve tensions will decline further as quantities between anticipated demand and of drugs in each country and available resources and undertake competition among sellers further resource mobilization, increase and public information beginning with the donors who did and marketing campaigns are not pledge in the replenishment undertaken to increase awareness process. More effort will also among buyers. be needed to engage the major emerging economies and to pursue The Millennium Development Goals new opportunities in innovative Summit in September marked ten financing. years of effort towards achieving the world’s major development 2011 will also be a year to complete goals. The summit was an important implementation of a range of opportunity to show that health operational and management is the area of development where reforms to improve the Global progress over the last decade Fund’s efficiency and effectiveness has been most visible and to and increase the quality of service highlight the contribution of the that we are providing to countries. Global Fund to the remarkable It will also be the year in which results and impact that have been the Board and Secretariat will achieved. The summit provided be collaborating closely in the unprecedented visibility for the development of a new corporate Global Fund and served as an strategy for the Global Fund for the important platform for several period 2011-2016. donors to announce early pledges to the Global Fund’s Third Voluntary It is nearly ten years since the Replenishment. Global Fund was created as an unprecedented emergency The replenishment for the period response to scale up interventions 2011-2013 was the key corporate for the three diseases. Since then priority for 2010. The result of these it has contributed to remarkable efforts – US$ 11.7 billion pledged or advances in global health and projected in October – was achieved demonstrated a successful new through a huge collective effort by development model. As we adjust the entire Global Fund partnership. to the demands of rapid growth If converted to firm commitments, through a process of reforms and the pledged funding will provide develop an important corporate for the continuation of all programs strategy that will take us to the already approved by the Global deadline for the Millennium Fund Board for the period 2011 to Development Goals, the Global 2013. This means further substantial Fund will be set for its second scale-up of AIDS, TB and malaria decade of saving lives. programs in the coming years. The Board approved a fully-funded PROF. MICHEL D. KAZATCHKINE Round 10 in December, the Global Executive Director 6 | The Global Fund Annual Report 2010 LEttER FROM THE CHAIR AND VICE-CHAIR OF THE BOARD Over the course of the year, the Global Fund has continued to engage in a number of important initiatives to consolidate its role as a major global health financier. This included the launch and approval of the Tenth Call for Proposals. The Global Fund Annual Report 2010 | 7 This took place in the context of streams of funding. Additionally, In 2010 the Global inevitable tensions between the the Global Fund committed to Fund Board need to continue supporting efforts close collaboration with the World agreed to set that are saving and transforming Bank and the GAVI Alliance on lives, while exercising fiscal an innovative common funding bold, ambitious discipline during a period of global platform for financing health and measurable economic downturn. A particular system strengthening efforts. The objectives in saving concern shared by all stakeholders Global Fund’s Board also launched lives, averting was the need to ensure the the Comprehensive Reform long-term sustainability of the Working Group to strengthen the infections and organization while encouraging reform process and make actionable increasing the impact continued support of the high- recommendations on reform of its investments. performing country programs that priorities. have delivered remarkable results with Global Fund financing. The In this context, the need for replenishment outcome – raising greater accountability over the US$ 11.7 billion from donors for use of Global Fund financing the 2011-2013 period – was a was also an important focus of reminder of the global community’s the year with considerable work commitment to the sustainability to strengthen fraud prevention, of effective HIV, TB and malaria detection, investigation and action. programs. We take this opportunity to thank government and private We are confident that these donors whose confidence and measures will build upon the generosity made this possible, and successes of the past nine to encourage donors to fulfil their years as they chart the way commitments. forward to the future. In the march against time to meet DR TEDROS ADHANOM the Millennium Development GHEBREYESUS Goals, in 2010 the Global Fund Chair of the Board Board agreed to set bold, ambitious and measurable objectives in DR ERNEST LOEVINSOHN saving lives, averting infections Vice-Chair of the Board and increasing the impact of its investments, including by maximizing the benefits of those investments to broader health gains, particularly for women and children.